v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

COGNITIVE IMPAIRMENT WITH SLEEPING DIFFICULTIES AND DEPRESSION AMONG PAKISTANI POPULATION

AUTHORS:

Dr. Hafsah Rabbani, Dr. Anam Riaz, Dr. Noreena Baloch

ABSTRACT:

Introduction: Depression is a mental health disorder wherein low mood and low energy can affect a person’s thoughts, feelings, behaviour and sense of well-being. It is characterized by disturbed sleeping pattern, change in appetite, fatigue, irritability, reduced ability to concentrate, difficulty in decision making and even suicidal thoughts. Aims and objectives: The basic aim of the study is to analyze the cognitive impairment with sleeping difficulties and depression among Pakistani population. Material and methods: This cross sectional study was conducted at Nishtar Hospital Multan during January 2019 to July 2019 with the permission of ethical committee of hospital. The data was collected from patients with psychiatric disorders, any type of cognitive impairment such as dementia and mental retardation, patients on anti-depressants, females in post-partum period and patients who had undergone any traumatic event within the last six months. Results: Anxiety scores were strongly associated with depression scores (r=0.65, P <0.001). Hierarchical regression analysis was conducted to analyze significant predictors of cognitive difficulties and controlling effects of anxiety in their relationship. The first model, explained 14.1% variation in scores on CDS scale. According to it, high CDS scores were associated with female gender and PSQI scores. Conclusion: It is concluded that high prevalence of anxiety, depression and sleeping difficulties among the Pakistani people. These psychopathologies were further associated with cognitive deficits that affect their daily routine.

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.